Anti-fibrotic nintedanib—a new opportunity for systemic sclerosis patients?
Crossref DOI link: https://doi.org/10.1007/s10067-017-3867-3
Published Online: 2017-10-16
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Duarte, Ana Catarina
Santos, Maria José
Cordeiro, Ana
License valid from 2017-10-16